Setup

RXRX pulled back toward the SMA50 support area after recent strength.

Price remained near the short-term moving-average cluster without becoming overextended.

Earnings were approximately 42 days away, leaving the option cycle free of event risk.

Unlike larger core Wheel names, RXRX is a higher-volatility biotech. Position sizing was intentionally kept smaller so assignment risk remained controlled within the overall portfolio.

The ten-day expiration created elevated premium while keeping assignment near a technically defined support zone.

Structure

The put was sold at the $3.50 strike.

That level aligned closely with the SMA50 support zone.

Break-even sits near $3.38, providing additional cushion toward the SMA100 / lower support area.

The setup is speculative by nature.

Assignment quality remained the primary consideration.

Assignment Logic

Assignment at $3.50 would create an effective cost basis near $3.38 after premium.

That basis sits near the lower support zone and remains acceptable only as a smaller speculative Wheel position.

The objective is not to avoid assignment.

It is to own shares only at a price that already makes sense.

If assigned, the position moves into Covered Call management.

Premium Context

Premium was elevated.

IV remained high relative to broader market conditions.

The premium reflected:

  • biotech volatility
  • elevated implied volatility
  • low-priced stock risk
  • speculative assignment risk

High premium reflects volatility as much as opportunity.

Not free edge.

Trade Structure

Trade structure Entry snapshot
Ticker RXRX
Strategy CSP
Expiration Jul 10, 2026
Strike $3.50
Premium ~$0.12
Premium Type Elevated
Premium Collected ~$600
Collateral ~$17,500
Break-even ~$3.38
Support $3.35–3.50 (SMA100 / SMA50 support zone)
Setup Quality B

Management Plan

The $3.35–3.50 support area remains the key level to monitor.

A sustained break below that region would weaken the assignment thesis.

Position sizing remains intentionally small.

Assignment is acceptable only within that controlled allocation.

If assigned, Covered Calls become the next step of the Wheel Strategy.

Process Note

This trade was not selected because it offered the highest premium available.

RXRX was not selected because it is a biotech or because implied volatility was elevated.

It qualified because the strike aligned with support, earnings remained outside the option cycle, and the position represented only a small allocation within the portfolio.

The premium was compensation.

The structure was the reason.

Assignment is part of the Wheel Strategy.

No prediction.

Just process.

Wizolver.log documents a personal trading process and is provided for educational and informational purposes only. Nothing here is financial advice or a recommendation to buy or sell any security. Options trading involves significant risk. Do your own research.